Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:09 pm Unchanged |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
James E. Flynn | 10,000,000 8.060% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:09 pm Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
James E. Flynn | 1,175,131 4.800% |
-630,906 (-34.93%) |
Filing History |
| 2022-02-11 4:08 pm Purchase |
2021-12-31 | 13G | AdaptHealth Corp. AHCO |
James E. Flynn | 24,272,428 7.720% |
2,871,653 (+13.42%) |
Filing History |
| 2022-02-11 4:08 pm Purchase |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
James E. Flynn | 4,695,020 9.910% |
2,159,519 (+85.17%) |
Filing History |
| 2022-02-08 1:33 pm Sale |
2021-12-31 | 13G | Brookdale Senior Living Inc. BKD |
James E. Flynn | 4,274,808 2.310% |
-6,748,657 (-61.22%) |
Filing History |
| 2022-01-24 4:43 pm Purchase |
2022-01-13 | 13G | Silk Road Medical, Inc SILK |
James E. Flynn | 1,861,917 5.340% |
1,861,917 (New Position) |
Filing History |
| 2021-12-07 5:19 pm Purchase |
2021-12-07 | 13G | Esperion Therapeutics, Inc. ESPR |
James E. Flynn | 10,000,000 8.170% |
10,000,000 (New Position) |
Filing History |
| 2021-12-03 3:07 pm Purchase |
2021-11-29 | 13G | Kura Oncology, Inc. KURA |
James E. Flynn | 3,513,756 5.280% |
3,513,756 (New Position) |
Filing History |
| 2021-11-19 5:19 pm Purchase |
2021-11-12 | 13D | DFP Healthcare Acquisitions Corp. DFPH |
James E. Flynn | 24,074,650 4.900% |
13,614,650 (+130.16%) |
Filing History |
| 2021-11-10 4:59 pm Purchase |
2021-11-05 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
James E. Flynn | 4,203,900 7.190% |
4,203,900 (New Position) |
Filing History |
| 2021-10-26 7:35 pm Purchase |
2021-10-26 | 13G | Xilio Therapeutics, Inc. XLO |
James E. Flynn | 2,287,944 8.580% |
2,287,944 (New Position) |
Filing History |
| 2021-09-28 11:29 am Purchase |
2021-09-20 | 13G | Vincerx Pharma, Inc. VINC |
James E. Flynn | 68,966 6.560% |
68,966 (New Position) |
Filing History |
| 2021-08-26 4:20 pm Purchase |
2021-08-23 | 13D | Acutus Medical, Inc. AFIB |
James E. Flynn | 5,852,924 9.500% |
345 (+0.01%) |
Filing History |
| 2021-08-16 5:06 pm Purchase |
2021-08-04 | 13G | Aerie Pharmaceuticals, Inc. AERI |
James E. Flynn | 2,535,501 5.370% |
2,041,285 (+413.03%) |
Filing History |
| 2021-08-05 4:45 pm Purchase |
2021-07-26 | 13G | Apria, Inc. APR |
James E. Flynn | 2,431,417 6.900% |
2,431,417 (New Position) |
Filing History |
| 2021-08-02 12:56 pm Purchase |
2021-07-22 | 13G | GeneDx Holdings Corp. WGS |
James E. Flynn | 419,651 5.770% |
419,651 (New Position) |
Filing History |
| 2021-07-21 5:13 pm Purchase |
2021-07-19 | 13D | Acutus Medical, Inc. AFIB |
James E. Flynn | 5,852,579 17.190% |
1,071,428 (+22.41%) |
Filing History |
| 2021-07-16 3:13 pm Purchase |
2021-07-13 | 13G | Pulmonx Corporation LUNG |
James E. Flynn | 1,950,887 5.380% |
1,950,887 (New Position) |
Filing History |
| 2021-07-13 4:52 pm Purchase |
2021-07-11 | 13D | Acutus Medical, Inc. AFIB |
James E. Flynn | 4,781,151 16.750% |
5,235 (+0.11%) |
Filing History |
| 2021-07-09 4:57 pm Purchase |
2021-06-29 | 13G | Organogenesis Holdings Inc. ORGO |
James E. Flynn | 7,694,363 6.000% |
7,694,363 (New Position) |
Filing History |